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Purpose: To study self-reported patient satisfaction and dry eye symptoms in hyperopic 
correction with femtosecond laser-assisted in situ keratomileusis (FS-LASIK).
Patients and methods: Ninety-eight eyes (53 patients) were treated with FS-LASIK for 
hyperopia. Patients’ self-reported dry eye symptoms and satisfaction with near and far vision 
were graded on the visual analog scale (VAS) preoperatively and 1 month postoperatively.
Results: Ninety-one percent of the eyes with the plano target (54 eyes) achieved an uncorrected 
distance visual acuity of 20/20 or better. Predictability, defined as spherical equivalent refraction 
within ±0.5 D of target, was 88% of all eyes. None of the eyes lost two or more Snellen lines of 
corrected distance visual acuity. There was no significant change in the self-reported dry eye 
sensation (VAS score from 2.7±2.0 to 2.8±2.0; P=0.66). In 44 monovision patients, satisfaction 
with both far vision (from 71.2±19.8 to 89.2±8.7; P,0.0001) and near vision (from 51.7±26.2 
to 89.3±13.2; P,0.0001) increased significantly. In nine emmetropic patients, satisfaction 
with neither far vision nor near vision was significantly improved, although there was a clear 
tendency (from 73.7±23.7 to 86.9±15.3; P=0.22, and from 58.9±29.1 to 81.6±17.4; P=0.11, 
respectively). In the monovision patient group, far vision satisfaction decreased when dry eye 
symptoms increased. Monovision patients, as predicted, were more satisfied with their near 
vision, when postoperative spherical equivalent from target was on the myopic side.
Conclusion: FS-LASIK correction of hyperopia significantly improved patient satisfaction 
with both near and far vision in monovision patients. Hyperopic patients had no significant 
changes in postoperative dry eye symptoms compared to preoperative values.
Keywords: femtosecond laser in situ keratomileusis, FS-LASIK, hyperopia, dry eye, patient 
satisfaction
Plain language summary
The most widely used refractive surgery to improve vision without spectacles or contact 
lenses is laser-assisted in situ keratomileusis (LASIK). In femtosecond-LASIK (FS-LASIK), 
a thin corneal flap is made with a femtosecond laser. The cornea under the lifted flap is then 
ablated with the excimer laser to reshape the cornea. We studied dry eye symptoms and patient 
satisfaction of hyperopic (farsighted) eyes treated with FS-LASIK. Hyperopic patients had 
no significant changes in postoperative dry eye symptoms compared to preoperative values. 
The risk of increased dry eye symptoms after hyperopic FS-LASIK correction seemed to be 
as low as in myopic (near sighted) FS-LASIK correction shown in our previous studies. In 
hyperopic monovision patients, satisfaction with both far and near vision improved significantly. 
Monovision patients had one eye corrected for far vision and the other eye for near vision. In 
monovision patients, satisfaction with far vision decreased when dry eye symptoms increased.
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Introduction
In laser-assisted in situ keratomileusis (LASIK) surgery, 
LASIK-associated dry eye symptoms have been reported 
to be the main reason for patient dissatisfaction.1 Corneal 
refractive surgeons also report dry eyes as the most common 
complication of LASIK.2 Transient dry eye symptoms 
immediately after surgery are reported by up to 95% of 
LASIK patients.3
Hyperopic correction has been considered challenging, 
but it has been treated successfully with many techniques.4–9 
Based on three LASIK studies utilizing microkeratomes 
for flap creation from 1997 to 1998, the overall satisfaction 
rate for patients undergoing hyperopic LASIK surgery was 
96.3% and the overall dissatisfaction rate 3.7%.10 In a more 
recent study also utilizing a microkeratome, the quality of 
vision was reported as unchanged, better, or significantly 
better at 12 months as compared to preoperative quality 
in 96.5% of spherical hyperopes and 94.4% of hyperopic 
astigmatism. Patient satisfaction and dry eye symptoms in 
hyperopic patients treated with FS-LASIK have rarely been 
investigated.11–15 The present study was undertaken to fill 
the void in knowledge in how patient satisfaction and dry 
eye symptoms are affected in patients treated for hyperopia 
with FS-LASIK. Both emmetropia-targeted patients and 
monovision patients were included and separately analyzed. 
In addition to clinical examinations, patient satisfaction with 
near and far vision and dry eye symptoms were investigated 
with a self-graded questionnaire. Patients graded their 
satisfaction and symptoms on the visual analog scale (VAS) 
before the treatment and 1 month postoperatively.
Patients and methods
Fifty-three patients (31 females and 22 males, 98 eyes) were 
involved in this retrospective study. Patients were scheduled 
for FS-LASIK correction for hyperopia at Silmäasema Eye 
Hospital, either in Tampere or in Helsinki (Finland) between 
May and December 2016. For the study, we used technical 
data of the surgery, clinical patient data, and quality control 
data of patient satisfaction. When a retrospective study 
with existing patient data is done, the approval of the Ethics 
Committee is not needed according to the EU legislation. 
The used data was de-identified.
Preoperative examinations
All patients had a complete preoperative ophthalmologic 
examination before the surgery to exclude any pathology 
that might be a contraindication for the surgery. In addition 
to biomicroscopy, evaluation of refraction and measurements 
of uncorrected and corrected distance visual acuity (UDVA 
and CDVA, respectively), examination included the 
measurement of intraocular pressure (iCare TA01i; iCare 
Finland Oy, Vantaa, Finland), corneal thickness, keratom-
etry readings (K
1
, K
2
, and K axis) and three-dimensional 
corneal topography (Allegro Oculyzer; Wavelight AG, 
Erlangen, Germany), and wavefront analysis (Allegro Ana-
lyzer; Wavelight AG). The use of soft contact lenses was 
discontinued a minimum of 1 week before the surgery.
surgical techniques
The surgeries were performed by a single experienced sur-
geon (JP). Prior to the surgery, the following topical eye drop 
medication was instilled into the eyes: antibiotic levofloxacin 
5 mg/mL (Oftaquix; Santen Oy, Tampere, Finland); diclof-
enac 1 mg/mL for pain and inflammation (Voltaren Ophtha; 
THEA, Clermont-Ferrand, France); brimonidine tartrate 
2 mg/mL to constrict conjunctival vessels (Alphagan; 
Allergan, Westport, Ireland); and a topical anaesthetic 
oxybuprocain hydrochloride 4 mg/mL (Oftan Obucain, 
Santen Oy). An aspirating speculum (Geuder, no 15,961, 
Heidelberg, Germany) was used to open the eyelid.
The femtosecond laser used for flap creation was FEMTO 
LDV Z6 I (Ziemer Ophthalmic Systems, Port, Switzerland) 
in Tampere (28 patients, 53% of the patients), and Visumax® 
(Carl Zeiss Meditec, Jena, Germany) in Helsinki (25 patients, 
47% of the patients). The FEMTO LDV Z6 I delivers 100 nJ 
pulse energy and 10 MHz repetition rate. A single-use plastic 
suction ring with 9.5-mm diameter was used to create a round 
flap with a target diameter of 9.3 mm and hinge length of 
4.0 mm. The target flap thickness was 90 or 100 µm and 
the flap edge angle was set from 60° to 90°. The vacuum 
pressure was 700 mbar and the cutting time 28 seconds. 
When the Visumax was used, the target flap thickness was 
also 90 or 100 µm and the flap edge angle was set at 60°. 
The M glass suction ring was used with a target flap diameter 
of 8.9 mm and target hinge length of 3.8 mm. The cutting 
time was 18 seconds. The excimer laser treatment was done 
in both hospitals with Wavelight EX500 (Wavelight AG, 
Erlangen, Germany).
Post-refractive treatment
Chloramphenicol- and dexamethasone-containing drops 
(Oftan Dexa-Chlora, Santen Oyj) with the tapered dose were 
used for the first 7 days – on the operation day for every 
2 hours; on day 2 for five times daily; on days 3 and 4 for 
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four times daily; on days 5 and 6 for three times daily; and 
on day 7 for two times daily. Artificial tear drops were used 
as needed from day 1. Gel-like moisturizing eye drops were 
used for the night and every morning. The frequency of using 
artificial tears was not monitored.
Follow-up examinations
On the follow-up visit 1 month postoperatively, the same 
examinations carried out preoperatively excluding wavefront 
analysis, were performed, and a patient questionnaire was 
filled in. All complications during the procedures and the 
1-month follow-up time were recorded.
Patient questionnaire
Patients filled a questionnaire before the operation and 
1 month postoperatively to rate their subjective dry eye 
symptoms and satisfaction for far vision and near vision 
separately. Dry eye symptoms were graded on the VAS 
from 0 (no dryness) to 10 (extremely dry eyes). The patients 
also rated their satisfaction for far and near vision separately 
on the VAS from 0 (poor) to 100 (excellent). The patients 
marked their subjective response on the linear visual line, and 
the length of the line segment was measured and recorded 
for analyses.
For 44 of the 53 patients, a monovision approach 
was used; the dominant eye was targeted for emmetropia 
while the non-dominant eye had a myopic target sphere 
(from −0.25 to −1.75 D). Patient selection criteria are shown 
in Figure 1. Five patients were targeted for emmetropia in 
both eyes, four patients had only one eye treated and targeted 
for emmetropia, and four patients had a myopic target sphere 
(from −1.25 to −1.75 D) in one eye.
statistical methods
The data were collected and entered into Excel study 
spreadsheets (Microsoft Corp., Redmond, WA, USA). 
Values were given as the mean ± standard deviation. The 
paired Student’s t-tests were used for statistical analysis to 
compare data before and after the treatment. Correlations 
were used to analyze the relationship between different 
parameters. The correlations were calculated using the eye 
with the best postoperative UDVA. For patient satisfaction 
with near vision, the correlations were calculated using the 
eye with the myopic target for near vision. We studied the 
correlations with subjective dry eye symptoms and patient 
satisfaction with emmetropia and monovision patient data 
using the following factors: pre- and postoperative spherical 
equivalent (SEQ) refraction, postoperative SEQ refraction 
error from the target, postoperative UDVA, postoperative 
cylinder, postoperative keratometry readings, and patient 
age. The statistical tests were performed with the GraphPad 
Prism software (San Diego, CA, USA). A P-value ,0.05 SDWLHQWVH\HV
H\HVHPPHWURSLD
0RQRYLVLRQSDWLHQWVH\HV H\HVP\RSLFWDUJHW
(PPHWURSLDSDWLHQWVH\HV
PRQRYLVLRQSDWLHQWVH\HV SDWLHQWVP\RSLFWDUJHWIRURQHH\HH\HV HPPHWURSLDSDWLHQWVH\HV SDWLHQWVHPPHWURSLDWDUJHWIRURQHH\HH\HV
Figure 1 Flowchart of patient selection.
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was considered statistically significant. Standard graphs 
and other figures were created using the SigmaPlot software 
(Systat Software, San Jose, CA, USA).
Results
Ninety-eight eyes of 53 patients were treated with FS-LASIK 
for hyperopia. The patients’ age range was between 22 and 
62 (mean age 49.6±9.8 years). All patients completed the 
1-month follow-up examination.
refraction
Preoperative and postoperative patient data are presented in 
Table 1. The standard graphs for reporting refractive surgery out-
comes are presented in Figure 2. The preoperative mean sphere 
Table 1 Preoperative and postoperative patient data
Variable Preoperative 1 month P-value
sphere (D) +2.24±1.25
(range: +0.25 to +6.25)
(n=98 eyes)
+2.08±1.10
(range: +0.025 to +4.25)
(n=44 monovision eyes)
+2.37±1.35
(range: +0.75 to +6.25)
(n=54 emmetropic eyes)
−0.54±0.98
(range: −2.75 to +1.25)
(n=98 eyes)
−1.53±0.61
(range: −2.75 to +0.25)
(n=44 monovision eyes)
+0.17±0.37
(range: −0.50 to +1.25
(n=54 emmetropic eyes)
,0.0001
,0.0001
,0.0001
Cylinder (D) −0.71±0.90
(range: 0 to 5.50)
(n=98 eyes)
−0.55±0.60
(range: 0 to 2.00)
(n=44 monovision eyes)
−0.83±1.08
(range: 0 to 5.50)
(n=54 emmetropic eyes)
−0.20±0.30
(range: 0 to 1.25)
(n=98 eyes)
−0.22±0.33
(range: 0 to 1.25)
(n=44 monovision eyes)
−0.18±0.28
(range: 0 to 1.00)
(n=54 emmetropic eyes)
,0.0001
0.0003
,0.0001
spherical equivalent
refraction (D)
+1.88±1.17
(range: +0.13 to +5.10)
(n=98 eyes)
+1.80±1.07
(range: +0.13 to +3.88)
(n=44 monovision eyes)
+1.95±1.26
(range: +0.25 to +5.10)
(n=54 emmetropic eyes)
−0.70±0.96
(range: −2.75 to +0.88
(n=98 eyes)
−1.65±0.54
(range: −2.75 to −0.13)
(n=44 monovision eyes)
+0.08±0.31
(range: −0.50 to +0.88
(n=54 emmetropic eyes)
,0.0001
,0.0001
,0.0001
Keratometric power K1 (D) 42.66±1.52
(range: 39.50 to 47.40)
(n=98 eyes)
42.89±1.38
(range: 40.10 to 47.00)
(n=44 monovision eyes)
42.47±1.62
(range: 39.50 to 47.40)
(n=54 emmetropic eyes)
45.03±2.12
(range: 40.70 to 51.40)
(n=94 eyes)
46.07±1.90
(range: 40.70 to 50.90)
(n=43 monovision eyes)
44.15±1.91
(range: 41.40 to 51.40)
(n=51 emmetropic eyes)
,0.0001
,0.0001
,0.0001
Keratometric power K2 (D) 43.69±1.50
(range: 40.10 to 48.40)
(n=98 eyes)
43.79±1.43
(range: 40.40 to 47.70)
(n=44 monovision eyes)
43.61±1.74
(range: 40.10 to 48.40)
(n=54 emmetropic eyes)
46.10±2.12
(range: 41.00 to 54.30)
(n=94 eyes)
47.10±2.03
(range: 41.00 to 51.90)
(n=43 monovision eyes)
45.26±2.14
(range: 41.80 to 54.30)
(n=51 emmetropic eyes)
,0.0001
,0.0001
,0.0001
Notes: Values are presented as mean ± sD. P-values were calculated by student’s paired t-test.
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Figure 2 (Continued)
was +2.24±1.25 D (range +0.25 to +6.25 D) and the mean 
preoperative cylinder −0.71±0.90 D (range 0 to −5.50 D) for 
all eyes studied. The preoperative SEQ refraction was +1.88± 
1.17 D (range +0.13 to +5.10 D). The preoperative SEQ 
refraction for 54 eyes targeting emmetropia was +1.95±1.26 D 
(range +0.25 to +5.10 D) and the postoperative values for this 
group of eyes were +0.08±0.31 D (range −0.50 to +0.88D). 
The preoperative SEQ refraction for 44 eyes having a myopic 
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Figure 2 standard graphs for reporting refractive surgery outcomes. (A) UDVa, (B) UDVa vs CDVa, (C) change in CDVa, (D) seQ refraction attempted vs achieved 
in emmetropic eyes, (E) seQ refraction attempted vs achieved in monovision eyes, (F) seQ refraction accuracy, (G) refractive astigmatism, (H) Tia vs sia, (I) refractive 
astigmatism angle of error. in (D and G), the values within 0.5 D are shown by green line and those within 1.0 D by pink line.
Abbreviations: arith, arithmetic; abs, absolute; CC/wise, counter clockwise; C/wise, clock wise; CDVa, corrected distance visual acuity; preop, preoperative; postop, 
postoperative; seQ, spherical equivalent refraction; sia, surgically induced astigmatism; Tia, target-induced astigmatism; UDVa, uncorrected distance visual acuity.
target was +1.80±1.07 D (range +0.13 to +3.88 D) and the 
postoperative values for these eyes were −1.65±0.54 D 
(range −0.13 to −2.75 D). The mean postoperative 1-month 
SE refraction in all eyes was −0.70±0.96 D (range −2.75 
to +0.88 D) and the 1-month SE refraction from the target 
was −0.022±0.374 D (range −1.00 to +1.00 D).
Efficacy
Postoperatively, 91% of the emmetropic eyes (54 eyes) 
achieved an UDVA of 20/20 or better.
Predictability
At 1 month, the refraction was within ±0.50 D of mean 
target SEQ refraction in 88% of all eyes. The refraction 
was within ±1.00 D of mean target SE refraction in 100% 
in all eyes.
safety
One-month postoperatively, three eyes lost one Snellen 
line of CDVA. One of these eyes gained the lost line 
in the follow-up visit and one patient did not have any 
more follow-ups. One patient needed reoperation due to 
undercorrection after 2 months.
Patient questionnaire
Patient data regarding the self-reported dry eye symptoms 
and patient satisfaction with far and near vision are presented 
in Table 2. The mean score of the preoperative subjective 
dry eye sensation was 2.7±2.0. The dry eye sensation did not 
change significantly postoperatively (VAS score 2.8±2.0; 
P=0.59). Patient satisfaction with both far and near vision 
was significantly improved after 1 month (P,0.0001). The 
mean VAS score for patient satisfaction with far vision 
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Table 2 Pre- and postoperative dry eye symptoms and patient satisfaction graded by visual analog scaling scores
Variable Preoperative 1 month P-value
Dry eye symptoms 2.7±2.0
(range: 0.3–7.1)
(n=53 all patients)
2.8±2.0
(range: 0–8.0)
(n=53 all patients)
0.66
Patient satisfaction, far vision 71.6±20.3
(range: 15–100)
(n=53 patients)
71.2±19.8
(range: 28–100)
(n=44 monovision)
73.7±23.7
(range: 15–95)
(n=9 emmetropia)
88.8±10.0
(range: 50–100)
(n=53 patients)
89.2±8.7
(range: 60–100)
(n=44 monovision)
86.9±15.3
(range: 50–100)
(n=9 emmetropia)
,0.0001
,0.0001
0.22
Patient satisfaction, near vision 52.9±26.6
(range: 5–99)
(n=53 patients)
51.7±26.2
(range: 5–99)
(n=44 monovision)
58.9±29.1
(range: 11–86)
(n=9 emmetropia)
88.0±14.1
(range: 40–100)
(n=53 patients)
89.3±13.2
(range: 40–100)
(n=44 monovision)
81.6±17.4
(range: 50–100)
(n=9 emmetropia)
,0.0001
,0.0001
0.11
Notes: Values are presented as mean ± sD. P-values were calculated by student’s paired t-test. 
improved from 71.6±20.3 to 88.8±10.0 and that of near 
vision from 52.9±26.6 to 88.0±14.1 in all patients studied. 
Monovision (44 patients) and emmetropic patients (nine 
patients) were also analyzed as separate groups with respect 
to patient satisfaction with far and near vision. In monovision 
patients, satisfaction with both far and near vision increased 
significantly (P,0.0001, Table 2). In the emmetropia 
group, the mean patient satisfaction with far and near vision 
increased from 73.7±23.7 to 86.9±15.3 (P=0.22) and from 
58.9±29.1 to 81.6±17.4 (P=0.11), respectively, but was not 
statistically significant, most probably due to the small size 
of this group. Data for eyes treated either with the FEMTO 
LDV or with the Visumax femtosecond laser for flap cre-
ations were also separately analyzed, but there were no dif-
ferences between them. Postoperative keratometry readings 
affected neither dry eye symptoms nor patient satisfaction 
with far or near vision.
In our monovision group, there was a significant nega-
tive correlation between satisfaction with far vision and dry 
eye symptoms postoperatively (r=−0.31, 0.04; Figure 3A). 
Furthermore, in monovision patients, satisfaction with near 
vision correlated negatively with postoperative spherical 
equivalent refraction from target (r=−0.45, P=0.002; 
Figure 3B). In the emmetropia group, satisfaction with 
near vision correlated negatively with patient age (r=−0.69, 
P=0.04; Figure 3C).
Technical deviations and complications
With the FEMTO LDV femtosecond laser, the Barraquer 
eye speculum was used in two eyes. When the excimer laser 
was used in the FEMTO LDV group, eye tracker came off 
in one (1%) eye and was redocked. Opaque bubble layer 
was observed in two (2%) eyes treated with FEMTO LDV. 
Furthermore, there was a tear in one (1%) corneal flap 
created with the Visumax femtosecond laser. None of these 
complications affected the visual acuity of the patients.
Discussion
Hyperopic correction with LASIK has been considered 
challenging.16,17 In general, patients seeking hyperopic 
correction are older than those seeking refractive surgery due 
to myopia or astigmatism. In this study, patient age ranged 
from 22 to 62 years (mean 49.6±10.4 years). Therefore, 
majority of our patients were treated for presbyopia by using 
monovision approach.
In recent years, the refractive results of FS-LASIK 
for hyperopia with and without astigmatism have been 
reported by many authors9,12,18–30 (Table S1). In these studies, 
predictability, defined as SEQ refraction within ±0.50 D of 
target SEQ refraction, ranged from 50%9 to 95%.12 Efficacy, 
defined as an UDVA of 20/20 or better, ranged from 24%30 
to 95.7%.19 Safety, as the loss of two or more Snellen lines of 
CDVA, ranged from 0%12,19,22,24,25,29 to 6.5%.21 In the present 
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Figure 3 (A) in 44 monovision patients, satisfaction with far vision correlated negatively with postoperative dry eye experience (r=−0.31, P=0.04). Patient satisfaction with far 
vision decreased with increasing dry eye symptoms. (B) in 44 monovision patients, satisfaction with near vision correlated negatively with postoperative spherical equivalent 
refraction from target (r=−0.45, P=0.002). Patients were more satisfied with their near vision when postoperative spherical equivalent from target was on the myopic side. 
(C) in nine emmetropic patients, satisfaction with near vision correlated negatively with patient age (r=−0.69, P=0.04). Patient satisfaction with near vision decreased with 
patient age.
study, 88% of eyes achieved a predictability within ±0.50 D, 
91% of the eyes with the plano target achieved efficacy 
within #20/20, and no eyes lost two or more Snellen lines 
of CDVA.
Most of the studies published on patient satisfaction 
with LASIK involve all types of refractive corrections, and 
the studies do not separately report the satisfaction rates 
for myopia or hyperopia, with or without astigmatism. In a 
study that analyzed the satisfaction of 13,566 patients with 
laser vision correction, using either LASIK or laser epithelial 
keratomileusis, 95% of patients reported being satisfied with 
their visual results after surgery and 82.8% of patients indi-
cated that their vision was better after surgery than it had been 
with spectacles or contact lenses.31 An LASIK review that 
analyzed the quality of life and patient satisfaction across all 
sorts of treatments reported an overall patient satisfaction of 
95.4%.10 On the subjective questionnaire of US naval aviators 
who had FS-LASIK, 95% of patients reported that their 
postoperative vision was better than the preoperative one.12 
A long-term follow-up (19.9±24.4 months, between 2000 
and 2012) of laser vision correction in physicians by pho-
torefractive keratectomy or LASIK reported an overall sat-
isfaction rate of 95.3%.15 Of the physicians, 84.4% reported 
an improvement in the quality of vision compared with the 
corrected preoperative vision. A study that compared visual 
satisfaction with LASIK and contact lenses reported that 
88% of former contact lens wearers and 77% of former glass 
wearers were strongly satisfied with LASIK at 3 years.14
Monovision is a method for presbyopia correction where 
the dominant eye is typically corrected for distance vision 
(emmetropia) and the non-dominant eye is corrected for 
near vision (myopic target). In monovision patients, high 
levels of patient satisfaction with LASIK utilizing micro-
keratomes for flap creation have been reported. Goldberg32 
reported 96% satisfaction and Miranda and Krueger33 
reported 92.5% success rate in myopes and hyperopes groups. 
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Later, Goldberg reported a patient satisfaction of 8.22 on a 
scale from 1 to 10 in monovision hyperopes with a follow-up 
from 6 to 24 months.34 Assil et al35 reported a mean overall 
patient satisfaction of 8.8 (scale 1 to 10) for hyperopic pres-
byopia with 6-month follow-up. In the present study, the 
postoperative patient satisfaction for far vision in all patients 
was 88.5, and for near vision it was 87.9. The corresponding 
values for monovision patients were 89.2 and 89.3, respec-
tively. In monovision patients, patient satisfaction for both 
far and near vision improved significantly within the follow-
up time. In our monovision patients, satisfaction with far 
vision decreased when dry eye symptoms increased. In this 
group, as expected, satisfaction with near vision was more 
evident when postoperative spherical equivalent from target 
was on the myopic side. In emmetropic patients, satisfaction 
with their near vision decreased with patient age. According 
to the results, monovision correction could be favorable for 
patients even under the age of 40 years.
Albietz et al36 have reported increased dry eye symptoms 
in hyperopic LASIK patients by using physiological mea-
surements. They speculated that differences in the surface 
contour following myopic and hyperopic ablations may 
contribute to increased dry eye symptoms in hyperopic 
patients.36 The most prominent difference between hyper-
opic and myopic treatments is that in the hyperopic LASIK 
ablation, the effect is the steepening of the cornea, while in 
the myopic ablation the effect is a central flattening. The 
steeper central cornea in hyperopic correction may adversely 
affect tear film stability and blinking patterns.36 Williams 
et al37 found that patients with steeper pre- and postopera-
tive K-values have more postoperative dry eye symptoms 
than patients with flatter K-values. In both of those studies, 
LASIK flaps were made with microkeratome.36,37 However, 
in the present study, postoperative keratometry values did 
not affect dry eye symptoms. Our patients did not report any 
significant changes in their self-reported dry eye symptoms 
during the follow-up. Therefore, the corneal flap seems to 
be one factor affecting postoperative dry eye symptoms after 
hyperopic LASIK.
In our previous studies, we compared FS-LASIK 
and SMILE for myopic treatment.38 In the comparison, 
myopic patients treated with FS-LASIK had no change in 
self-reported dry eye symptoms, but patients treated with 
SMILE reported fewer dry eye symptoms after 1-month 
follow-up than preoperatively. When FS-LASIK-corrected 
myopic eyes in our previous study and FS-LASIK-corrected 
hyperopic eyes in the present study were compared, 
we found no significant changes in postoperative dry 
eye symptoms. Salomão et al39 compared LASIK-induced 
dry eye symptoms in myopic eyes after flap creation 
with mechanical microkeratome and femtosecond laser. 
The incidence of LASIK-associated dry eye 1-month 
postoperatively was significantly higher in the microkera-
tome group (46%) than in the femtosecond group (8%). 
Flaps made with femtosecond laser are thinner and have less 
deviation in thickness than flaps made with microkeratome, 
causing less damage to the afferent sensory nerves in the 
anterior corneal stroma and may therefore cause less post-
operative dryness.39 Our study suggests that FS-LASIK 
for hyperopia does not exacerbate dry eye symptoms 
even in eyes with steeper corneal curvature.
Our study had some limitations. The data used are based 
on the normal real-life data of the patients visiting refractive 
surgery clinics. This fact has its benefits and drawbacks. The 
results are representative and thus can be easily transferred 
to a clinical practice. We investigated dry eye experience 
but did not include any specific analyses of tear film or ocu-
lar surface in the study. Our follow-up time was 1 month, 
which did not allow further analyses over a longer period of 
time. On the other hand, the dry eye symptoms after LASIK 
are multifactorial and are known to be most evident during 
the first month after operation and diminish after that.40 
Although VAS are easy-to-use and practical methods and 
thus very suitable for the real-life type of studies, they have 
certain limitations. Patients often avoid marking in the ends 
of the VAS scale and thus the linearity of the satisfaction 
and symptom scale at the ends of VAS might be criticized. 
Refractive corrections for hyperopia are much more uncom-
mon that myopic corrections yielding relative low number 
of cases in these types of studies.
Conclusion
In conclusion, most of the patients in the present study 
were having monovision correction for presbyopia. We 
investigated dry eye symptoms and patient satisfaction for 
near and far vision preoperatively and 1 month after the 
operation using the self-reported VAS. There were no sig-
nificant changes in dry eye symptoms during the 1-month 
follow-up. In monovision patients, satisfaction with both far 
and near vision improved significantly during the follow-up. 
Also in them, patient satisfaction with far vision decreased 
when dry eye symptoms increased. As predicted, monovision 
patients were more satisfied with their near vision when 
postoperative spherical equivalent from target was on the 
myopic side. Satisfaction with near vision in emmetropic 
patients decreased with increasing age.
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